Beneath the frozen landscapes of Canada’s High Arctic, a stunning prehistoric discovery has emerged, challenging everything we thought we knew about ancient wildlife. Hidden for millions of years under ice and snow, the remains of a…
The commotion over asteroid 2024 YR4 hitting the moon can finally simmer down, as it has been announced that the moon is officially safe from impact. Watching the asteroid over the past year has been a roller coaster, as estimations of impact…
Humans and animals share a remarkable capacity to sense when others are in distress and respond with comforting behavior. But the motivation for doing so, and why it sometimes breaks down, has been poorly understood. UCLA Health researchers…
Global warming has accelerated over the past decade, according to a new analysis of global temperature records by researchers at the Potsdam Institute for Climate Impact Research (PIK).
The study finds that the pace of warming since 2015 has…
Noise sensitivity is a problem that often lacks diagnosis — it’s almost as if some doctors just aren’t listening. But the tendency to be irritated by persistent, ongoing noise affects all kinds of people — and it’s more than just a…
Planet Labs, one of the world’s leading commercial satellite imaging companies, said Friday it is placing a hold on releasing imagery of some parts of the Middle East as a regional war…
X is testing a new ad format that inserts a recommendation directly underneath a post that references the company or its products. The initial test, spotted by an X user in Europe, displayed a suggestion to “Get Starlink” beneath a post from…
A naturally occurring byproduct of liver metabolism—the ketone body, β-hydroxybutyrate (BHB)—can strengthen the fitness and antitumor activity of CAR T cells. The findings, reported on March 6, 2026 in the journal Cell, by Arc Institute and…
Nintendo filed a lawsuit against the U.S. government on Friday over its extraction of tariffs from global businesses. The gaming giant is seeking a refund for any duties it paid due to President Donald Trump’s executive orders that invoke the…
The weight-loss and diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists — sold under brand names like Ozempic or Wegovy — may soon expand their treatment repertoire to address substance addiction. A large recent study involving…
